Deerfield Management Town Hall

How do academic investigators work with investors to turn promising scientific ideas into real-world companies?

Please join us for a conversation with the Deerfield team to explore their work in advancing academic innovation through Pinnacle Hill, Deerfield’s partnership with UNC-Chapel Hill.

Deerfield is an investment firm dedicated to advancing healthcare through investment, intelligence, and philanthropy. The firm’s internal research and development team, 3DC, is a partner to various stakeholders in the biotech ecosystem, including principal investigators in Deerfield’s academic collaboration network, as well as startups, and biopharma companies.

What you’ll learn:

• How Deerfield and 3DC partner with academic medical centers and aim to turn research and clinical ideas into real-world healthcare innovations and new biotech ventures
• What capabilities and resources Deerfield can bring to help enable productive partnerships with University of North Carolina scientists and clinicians
• What Deerfield’s areas of interest are for academic collaborations, and how to engage

Members of the University of North Carolina biomedical ecosystem likely to find this most interesting:

• Faculty, students, and staff involved in translational research
• Clinicians and medical center leaders interested in industry collaborations
• Biomedical innovation leaders and entrepreneurs

SPEAKERS

William Slattery, Partner, Therapeutics Investment Team

Nadim Shohdy, Ph.D., Chief Operating Officer, Deerfield Discovery and Development